Aaron Grey

Benjamin Piggott

John McCaulis

Matt Devlin

Michael Albanese

- Upexi reported **$15.8 million** in revenue and a **net loss of $13.7 million** for the fiscal year ended June 30, 2025.  **[1775194_0001477932-25-007090_upxi_ex991.htm:0]** 
- As of September 10, 2025, Upexi held **2,018,419 SOL**, marking a **174% increase** from June 30, 2025.  **[1775194_0001477932-25-007090_upxi_ex991.htm:0]** 
- The company's Net Asset Value reached **$433 million** as of September 23, 2025, an increase of **281%** from June 30, 2025, with an unrealized gain of **$128 million**.  **[1775194_0001477932-25-007090_upxi_ex991.htm:0]** 
- Adjusted SOL per share was **$4.23** on September 23, 2025, up **101%** from June 30, 2025, with substantially all SOL being staked to earn an approximate **8% yield**.  **[1775194_0001477932-25-007090_upxi_ex991.htm:0]**

UPEXI Reports Fiscal Year 2025 Results and Solana Treasury Update

- Upexi's Solana treasury held **2,018,419 SOL** valued at **$447 million** as of **September 10, 2025**, reflecting an **unrealized gain of $142 million**.  **[1775194_0001477932-25-006712_upxi_ex991.htm:0]** 
- The company reported a **129% increase** in its adjusted SOL per share since the treasury launch, reaching **$4.37** (or **0.0197 SOL**) as of **September 10, 2025**.  **[1775194_0001477932-25-006712_upxi_ex991.htm:0]** 
- Substantially all of Upexi's SOL holdings are being staked, generating approximately **$105,000 per day in revenue** from an **~8% yield**.  **[1775194_0001477932-25-006712_upxi_ex991.htm:0]**

Upexi Provides Update on Solana Treasury and Adjusted SOL per Share

- On **August 22, 2025**, Upexi, Inc. (UPXI) executed and closed an agreement to invest in Alpha Exchange, a next-generation cryptocurrency trading platform.  **[1775194_0001477932-25-006316_upxi_8k.htm:0]** **[1775194_0001477932-25-006316_upxi_8k.htm:1]** 
- The initial investment by UPXI is **$750,000**, in exchange for a royalty equal to **14.9% of all future gross revenue** generated by Alpha Exchange Platform.  **[1775194_0001477932-25-006316_upxi_8k.htm:1]** 
- The agreement provides for two additional **$250,000** investments, contingent on Alpha Exchange achieving **10,000** and **25,000 active users**, respectively.  **[1775194_0001477932-25-006316_upxi_8k.htm:1]** 
- Upon the first additional investment (at 10,000 active users), UPXI's royalty interest would increase to **19.9% of gross revenue**.  **[1775194_0001477932-25-006316_upxi_8k.htm:1]** 
- After the second additional investment (at 25,000 active users), UPXI will have the option to either maintain its **19.9% royalty in perpetuity** or convert a portion of its interest into a **9.99% equity stake** in Alpha Exchange on a fully diluted basis.  **[1775194_0001477932-25-006316_upxi_8k.htm:1]**

Upexi, Inc. invests in cryptocurrency trading platform

- Upexi, Inc. entered into a Waiver and Amendment Agreement on **August 25, 2025**, with Purchasers to amend a prior Securities Purchase Agreement dated July 11, 2025.  **[1775194_0001477932-25-006234_upxi_ex101.htm:0]** **[1775194_0001477932-25-006234_upxi_8k.htm:1]** 
- This agreement grants Upexi a **one-time waiver** from compliance with Section 4.12 of the Securities Purchase Agreement to facilitate a **Subsequent Equity Sale**.  **[1775194_0001477932-25-006234_upxi_ex101.htm:0]** **[1775194_0001477932-25-006234_upxi_8k.htm:1]** 
- The proceeds from this offering are intended to further develop the Company's **Solana and cryptocurrency treasury**.  **[1775194_0001477932-25-006234_upxi_ex101.htm:0]** 
- As part of the agreement, Upexi will issue **greenshoe instruments** to Purchasers, allowing them to purchase additional shares of Common Stock equal to **25%** of their initial Subscription Amount under the Securities Purchase Agreement.  **[1775194_0001477932-25-006234_upxi_8k.htm:1]** 
- The Company is required to file a registration statement covering the resale of these Instrument Shares within **60 calendar days** of their initial issuance.  **[1775194_0001477932-25-006234_upxi_ex102.htm:13]**

UPEXI (UPXI)